Brain and eye diseases and disorders are on the rise, exponentially

Early detection is effective at diminishing the severity of disease progression. However, modern clinical practices and imaging tools are not conducive for weekly or even monthly exams needed to capture disease progression early.

—

Our current healthcare system
is not equipped to face these
growing numbers:

Accessible, intelligent,
easy-to-use retinal
imaging system

to solve these problems at scale.

The Neuro-i SS-OCT is a medical device pending FDA clearance that produces automated, high-performance, and repeatable imaging and analysis of retina structure and microvasculature. This technology is expected to aid clinicians in delivering more diligent diagnostic reports to patients in a timely manner.

JuneBrain®'s retinal imaging technology has the potential to identify neurological and eye diseases for the more than 1.3 billion individuals worldwide suffering from these conditions.

JuneBrain® is empowering eye care and
neurology communities through remote disease monitoring

—

JuneBrain® uses the retina's power to provide physicians with the insight needed to visually assess ocular and neurological disease progression.

The Neuro-i SS-OCT

Optical Coherence Tomography

---

How it works

---

---

Accessible + intelligent software

---

From grant awards & investors to a $300k+ customer pipeline 

---

Early Traction

---

—

Projected revenue*

We target customers in need of a portable and low-cost way to measure disease

• Neurology + eye clinics
• Telehealth programs
• Retail Eye Centers
• Pharmacies 
• Primary care and urgent care clinics
• Senior living homes
• Pharmaceutical clinical trials
• Patient homes

—

LOIs and customer pipeline

JuneBrain®'s go-to-market and growth strategies

Entry Market: Clinical Trials, University Research Groups, Pharmaceutical Companies

Target Market: In-Clinic Use and Pharmacies

Future Market: Patient Homes & Residential Long-term Care Facilities

—

Revenue model:

Hardware + Recurring SaaS Sales

Insurance codes exist to reimburse
providers for patient eye exams

Eye care is an outdated industry…

—

...and brain and eye diseases
suffer from poor monitoring:

Uniquely positioned in the vision diagnostics space

Comparing raw images of the same model retina
JuneBrain® endeavors to capture clinically equivalent images for a fraction of the hardware cost. JuneBrain®'s innovation uses AI and is expected to expedite diagnostics to capture market share from the $1.5B retinal photographer market.

From seed to scale

How JuneBrain® disrupts the OCT industry:

---

Potential Customers

---

---

Potential Strategic Partners

---

Licensing to or partnering with a pharmaceutical company or strategic partner(s) with a strong presence in the telehealth market.

Pharmacy chain currently expanding their telehealth options to improve access to care for chronic disease patients

Major manufacturer of optical systems; recent acquisitions include: Bioptigen (2015), a portable OCT company

Major biotechnology company with interest in telehealth; recent programs include: Home-Based MS Telemedicine program (UC Riverside, 2017)

Major manufacturer of optical systems raised $367 million in 2019 for future acquisitions

$1.7M in grant funding,

Including federal SBIR awards and international competition winnings
—
$585k from VCs, angels, friends and family

Samantha Scott, PhD

Founder and CEO of JuneBrain®, Inc.
Retinal and brain imaging expert

---

Our story

---

When Dr. Scott was diagnosed with myasthenia gravis, a chronic neurological disorder, she found an immediate flaw in our healthcare system: her neurologist only had the bandwidth to see her once a year. As a result, she was left on her own to understand how her disease was changing and communicate those changes to her doctor. This common clinical practice places a great burden on patients to monitor their own diseases but provides clinicians with only subjective information.

She founded JuneBrain® in response to this challenge, which is shared by a diversity of individuals living with eye and brain disease, including multiple sclerosis and macular degeneration. 

This challenge, combined with Dr. Scott’s passion for brain and eye research and developing technologies that help patients and those that care for them, was the inspiration for her founding JuneBrain.

---

Education

---

• PhD in Biomedical Engineering from the University of Southern California
• Graduate Certificate in Technology Commercialization from USC’s Marshall School of Business
• BS in Biomechanical Engineering from Stanford University
• Postdoc completed at NIH | NIAAA’s Laboratory of Neuroimaging
• Artificial Intelligence tutorial completed at Oxford University

---

Capabilities

---

14 years experience with:

• Customer-driven product development
• Neuroimaging research in patients with retinal disease
• Leading multidisciplinary teams to design and test medical devices for the retina
• Technology commercialization